Provided by Tiger Trade Technology Pte. Ltd.

AstraZeneca PLC

158.78
-1.3400-0.84%
Post-market: 158.990.2100+0.13%19:07 EDT
Volume:3.49M
Turnover:552.74M
Market Cap:246.27B
PE:23.77
High:160.05
Open:159.80
Low:156.72
Close:160.12
52wk High:212.71
52wk Low:153.41
Shares:1.55B
Float Shares:1.50B
Volume Ratio:1.32
T/O Rate:0.23%
Dividend:3.17
Dividend Rate:2.00%
EPS(TTM):6.68
EPS(LYR):6.54
ROE:21.96%
ROA:8.21%
PB:4.90
PE(LYR):24.28

Loading ...

Global Pharma Companies That Have Publicly Announced Trump Drug Pricing Agreements

Reuters
·
Sep 01

AstraZeneca completes global license agreement for Zegfrovy in lung cancer

TIPRANKS
·
Sep 01

AstraZeneca Reports 'Meaningful Improvement' in Phase 3 Study of Lung Cancer Patients

MT Newswires Live
·
Sep 01

AstraZeneca Says Breast Cancer Combo Approved in EU; Completes Acquisition of License for Lung Cancer Treatment

MT Newswires Live
·
Sep 01

Movement Alert|AstraZeneca PLC Declines 4.14% Overnight, Competitive Threat From Summit Ivosdenib Data Weighs on Immuno-Oncology Outlook

Market Focus
·
Sep 01

AstraZeneca PLC Stock Rises Monday, Outperforms Market

Dow Jones
·
Sep 01

Hutchmed Says Lung Cancer Therapy Improves Progression-Free Survival in China Phase 3 Trial

MT Newswires Live
·
Aug 31

AstraZeneca PLC Stock Falls Friday, Underperforms Market

Dow Jones
·
Aug 29

Jefferies sees neutral to negative read-through to Alnylam from AstraZeneca data

TIPRANKS
·
Aug 28

AstraZeneca Targets Pediatric Asthma Gains With New Glycopyrronium Trial

TIPRANKS
·
Aug 28

AstraZeneca Advances Off‑the‑Shelf CAR‑T Program in Tough‑to‑Treat Multiple Myeloma

TIPRANKS
·
Aug 28

Amgen, AstraZeneca announce Crossing trial showed ‘meaningful’ improvements

TIPRANKS
·
Aug 27

Amgen, AstraZeneca report CROSSING trial met co-primary and secondary endpoints

TIPRANKS
·
Aug 27

AstraZeneca, Amgen Phase 3 Trial Shows Tezspire Eases Swallowing Difficulties for EoE Patients

MT Newswires Live
·
Aug 27

AstraZeneca's Tezspire Meets Esophagitis Late-Stage Trial Goals

Dow Jones
·
Aug 27

AstraZeneca Slides Wednesday, Underperforms Market

Dow Jones
·
Aug 27

AstraZeneca Deepens Its Type 2 Diabetes Pipeline With New Global Patient Mapping Study

TIPRANKS
·
Aug 26

AstraZeneca Climbs Tuesday, Outperforms Market

Dow Jones
·
Aug 26

AstraZeneca (AZN) Receives a Sell from Deutsche Bank

TIPRANKS
·
Aug 25

Astrazeneca Prices $2.97 Billion Eurobond Offering

MT Newswires Live
·
Aug 25